Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Growth Hormone in the Pathogenesis and Treatment of Cardiac Steatosis and Diastolic Dysfunction in HIV

NCT03826160 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03826160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03826160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Growth Hormone in the Pathogenesis and Treatment of Cardiac Steatosis and Diastolic Dysfunction in HIV
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Completed
Start date
January 30, 2019
Completion date
April 19, 2022
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac disease, human immunodeficiency virus, lipodystrophy